Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 47 Breast Neoplasms 32 Colorectal Neoplasms 28 Prostatic Neoplasms 27 Lung Neoplasms 16 Hematopoietic and Lymphatic System Neoplasm 12 Hematologic Neoplasms 12 Ovarian Neoplasms 11 Uterine Cervical Neoplasms 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Multiple Myeloma 7 Lymphoma 7 Leukemia 7 Head and Neck Neoplasms 6 Endometrial Neoplasms 6 Depression 6 Rectal Neoplasms 5 Pancreatic Neoplasms 5 Urinary Bladder Neoplasms 4 Mouth Neoplasms 4 Motor Activity 4 Melanoma 4 Malignant Solid Neoplasm 4 Leukemia, Myeloid, Acute 4 Hematopoietic and Lymphoid System Neoplasm 4 Gastrointestinal Neoplasms 4 Colonic Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Anxiety Disorders 4 Advanced Cancer 4

Interventions

Cyclophosphamide 101 Etoposide 60 Carboplatin 55 Vincristine 51 Filgrastim 49 Topotecan 44 Temozolomide 44 Melphalan 44 Isotretinoin 44 Doxorubicin 44 Irinotecan 42 Cisplatin 35 3-Iodobenzylguanidine 34 Peripheral Blood Stem Cell Transplantation 31 dinutuximab 30 Granulocyte Colony-Stimulating Factor 30 Radiotherapy 29 sargramostim 28 Granulocyte-Macrophage Colony-Stimulating Factor 25 Busulfan 22 Magnetic Resonance Spectroscopy 19 aldesleukin 18 Thiotepa 18 fludarabine 17 Interleukin-2 17 humanized 3F8 anti-GD2 monoclonal antibody 16 etoposide phosphate 16 naxitamab 15 Ifosfamide 15 Biopsy 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neuroblastoma × Interviews as Topic × Clear all

NCT02780128 2026-03-10

NEPENTHE

Children's Hospital of Philadelphia

Phase 1 Terminated

Neoplasms, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡